Search research articles
Contact Us
Filters
Showing results (771-780 of 864) with videos related to
Page
of 87
Sort By:
Journal of Clinical Medicine
|
June 27, 2020
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
Monika Kozieł, Michał Mazurek, Christine Teutsch, et al.
European Heart Journal
|
September 4, 2014
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
Riccardo Cappato, Michael D Ezekowitz, Allan L Klein, et al.
Acta Pharmacologica Sinica
|
November 27, 2020
Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]vicagrel, a novel irreversible P2Y<sub>12</sub> inhibitor in humans
Yuan-Dong Zheng, Hua Zhang, Yan Zhan, et al.
World Journal of Pediatrics : WJP
|
December 23, 2022
Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome
Ruo-Qian Cheng, Yan-Qin Ying, Zheng-Qing Qiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 1, 2023
Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma
Le Li, Xing Zeng, Zheng Chao, et al.
International Journal of Cardiology
|
February 4, 2014
Left ventricular synchronization and systolic function estimated by speckle tracking echocardiography pre-and post-radiofrequency ablation in patients with atrial fibrillation
Jian Qiang Zhang, Jing Ping Sun, Xin Yao Liu, et al.
Journal of Cardiovascular Electrophysiology
|
June 3, 2018
Long-term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy
Xuan Chen, Jian-Zeng Dong, Xin Du, et al.
American Heart Journal
|
April 29, 2014
Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion
Michael D Ezekowitz, Riccardo Cappato, Allan L Klein, et al.
Clinical Cardiology
|
May 23, 2023
Catheter ablation of atrial fibrillation in patients with autoimmune disease: A propensity score matching study based on the China Atrial Fibrillation Registry
Ming-Yang Gao, Li-Hong Huang, Yi-Wei Lai, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 7, 2019
Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study
Lu Wang, Xin Du, Jian-Zeng Dong, et al.
Page
of 87
Search research articles
Search
Showing results (771-780 of 864) with videos related to
Sort By:
Page
of 87
Journal of Clinical Medicine
|
June 27, 2020
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
Monika Kozieł, Michał Mazurek, Christine Teutsch, et al.
European Heart Journal
|
September 4, 2014
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
Riccardo Cappato, Michael D Ezekowitz, Allan L Klein, et al.
Acta Pharmacologica Sinica
|
November 27, 2020
Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]vicagrel, a novel irreversible P2Y<sub>12</sub> inhibitor in humans
Yuan-Dong Zheng, Hua Zhang, Yan Zhan, et al.
World Journal of Pediatrics : WJP
|
December 23, 2022
Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome
Ruo-Qian Cheng, Yan-Qin Ying, Zheng-Qing Qiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 1, 2023
Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma
Le Li, Xing Zeng, Zheng Chao, et al.
International Journal of Cardiology
|
February 4, 2014
Left ventricular synchronization and systolic function estimated by speckle tracking echocardiography pre-and post-radiofrequency ablation in patients with atrial fibrillation
Jian Qiang Zhang, Jing Ping Sun, Xin Yao Liu, et al.
Journal of Cardiovascular Electrophysiology
|
June 3, 2018
Long-term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy
Xuan Chen, Jian-Zeng Dong, Xin Du, et al.
American Heart Journal
|
April 29, 2014
Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion
Michael D Ezekowitz, Riccardo Cappato, Allan L Klein, et al.
Clinical Cardiology
|
May 23, 2023
Catheter ablation of atrial fibrillation in patients with autoimmune disease: A propensity score matching study based on the China Atrial Fibrillation Registry
Ming-Yang Gao, Li-Hong Huang, Yi-Wei Lai, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 7, 2019
Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study
Lu Wang, Xin Du, Jian-Zeng Dong, et al.
Page
of 87